Contact Us
Home Jazz Pharmaceuticals Announces November 4 Conference Call to Discuss Third Quarter 2010 Results and Guidance

News Release

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 637 2141
US: 215-867-4948

Jazz Pharmaceuticals Announces November 4 Conference Call to Discuss Third Quarter 2010 Results and Guidance

October 28, 2010
PDF Version

PALO ALTO, Calif., Oct 28, 2010 /PRNewswire via COMTEX/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it will report its third quarter 2010 financial results on Thursday, November 4, 2010 at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. The company will discuss its financial results and guidance for 2010, and provide an overall business update.

The live webcast and press release may be accessed from the Investors section of the Jazz Pharmaceuticals website at http://www.jazzpharma.com/. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

Investors may also participate in the conference call by dialing 866-770-7125 in the U.S., or 617-213-8066 outside the U.S., and entering passcode 61488979.

An archived version of the webcast will be available for at least one week on the investors section of the Jazz Pharmaceuticals' website. An audio replay will also be available shortly following the call and can be accessed by dialing 888-286-8010 (U.S.); or 617-801-6888 (international) with a passcode of 89356526.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information see http://www.jazzpharmaceuticals.com/.

SOURCE Jazz Pharmaceuticals, Inc.